Insiders Enanta Pharmaceuticals, Inc.

Equities

ENTA

US29251M1062

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-07 pm EDT			5-day change	1st Jan Change
12.91 ^USD	+2.95%		+3.53%	+37.19%

May. 07	JMP Securities Adjusts Enanta Pharmaceuticals Price Target to $22 From $23, Maintains Market Outperform Rating	MT
May. 06	Transcript : Enanta Pharmaceuticals, Inc., Q2 2024 Earnings Call, May 06, 2024

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Enanta Pharmaceuticals, Inc. Appoints Matthew P. Kowalsky as Chief Legal Officer	Apr. 30	CI
Enanta Pharmaceuticals, Inc. Announces Retirement of Nathaniel S. Gardiner as Senior Vice President and General Counsel, Effective on or Before March 31, 2024	Dec. 26	CI
Insider Sell: Enanta Pharmaceuticals	23-03-15	MT
Insider Sell: Enanta Pharmaceuticals	23-02-14	MT
Insider Sell: Enanta Pharmaceuticals	22-12-19	MT
Enanta Pharmaceuticals, Inc. Announces Appointment of Scott T. Rottinghaus to the Position of Senior Vice President and Chief Medical Officer	22-08-08	CI
North American Morning Briefing : Stocks to Extend -2-	22-07-07	DJ
Insider Sell: Enanta Pharmaceuticals	22-04-06	MT
Insider Sell: Enanta Pharmaceuticals	22-03-04	MT
Insider Sell: Enanta Pharmaceuticals	21-12-06	MT
Insider Sell: Enanta Pharmaceuticals	21-10-14	MT
Enanta Pharmaceuticals, Inc. Elects Yujiro S. Hata as Independent Director	21-08-23	CI
Enanta Pharmaceuticals : Announces Nomination of Clinical Candidate EDP-235, its Lead Oral Protease Inhibitor Specifically Designed for the Treatment of COVID-19	21-08-05	BU
Enanta Pharmaceuticals, Inc. Announces Nomination of Clinical Candidate Edp-235, Its Lead Oral Protease Inhibitor Specifically Designed for the Treatment of Covid-19	21-08-05	CI
Enanta Pharmaceuticals : Chief Medical Officer To Retire	21-07-14	MT
Enanta Pharmaceuticals, Inc. Announces Retirement of Senior Vice President and Chief Medical Officer, Nathalie Adda in February 2022	21-07-14	CI
Enanta Pharmaceuticals, Inc. Appoints Brendan Luu as Senior Vice President, Business Development	21-01-26	CI
Insider Trends: 90-Day Insider Buying Trend at Enanta Pharmaceuticals Slowed with Sale of Shares	21-01-08	MT
Enanta Pharmaceuticals Announces the Appointment of John P. Devincenzo, M.D. as Vice President of Translational Virology	21-01-06	CI
Enanta Pharmaceuticals Announces the Appointment of Tara L. Kieffer, Ph.D. as Senior Vice President, New Product Strategy and Development	20-12-08	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Enanta Pharmaceuticals, Inc.

Equities

ENTA

US29251M1062

Insiders

Filters